Hrd1 antibody | knockout validation | Novus Biologicals NB100-2526
DOI
//dx.doi.org/10.13070/ko.en.6.1910
Date
2016-12-07

This is a knockout-validated antibody summary, based on the publication "IRE1α is an endogenous substrate of endoplasmic-reticulum-associated degradation", as cited below [1]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

Antibody information

Rabbit polyclonal

Company: Novus Biologicals

Antibody: Hrd1

Catalog number: NB100-2526

Summary: Rabbit polyclonal antibody raised against a synthetic peptide corresponding to a region within residues 300-400 of human Hrd1.

Supplier recommended for WB, IHC and ICC.

Reacts with human and mouse Hrd1.

Validation Method

Western blot

Sample

Lysates of wild-type and Hrd1 knockout mouse embryonic fibroblasts.

Primary incubation

Anti-Hrd1 diluted 1:8000.

Detection

Image Lab ChemiDOC XRS+ (BioRad).

Figure

See Figure 1 in [1].

Disclaimer

If the antibody described in this summary is a polyclonal antibody, since polyclonal antibodies are of limited quantity, please inquire the supplier whether any current polyclonal antibody with the same catalog number is exactly the same as the one described in this summary. Sometimes, different bleeds or different animals are used, usually with a different lot number. In such cases, the result in this summary may not apply to the new antibody with the same catalog number.

References
  1. Sun S, Shi G, Sha H, Ji Y, Han X, Shu X, et al. IRE1α is an endogenous substrate of endoplasmic-reticulum-associated degradation. Nat Cell Biol. 2015;17:1546-55 pubmed publisher